Slovenia's Salus extends validity of bid for 75% of Farmadent

Salus is still in talks for the acquisition of the 75% stake in Farmadent and hopes to sign an agreement for the transaction by November 3, Salus said in a filing with the Ljubljana Stock Exchange.

Salus submitted a binding bid for the purchase of the stake in Farmadent on September 24 and set October 19 as a deadline for the validity of its offer.

The bid includes an option for the purchase of the remaining 25% stake in Farmadent, or alternatively the company's entire capital.

The potential acquisition of Farmadent is in line with Salus' development strategy, which envisages expansion of activities in regions where the company is not yet present.